References
- Tomson C, Porter T. Asymptomatic microscopic or dipstick haematuria in adults: which investigations for which patients? A review of the evidence. BJU Int. 2002;90(3):185–198.
- Vivante A, Afek A, Frenkel-Nir Y, et al. Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease. JAMA. 2011;306(7):729–736.
- Cohen RA, Brown RS. Clinical practice. Microscopic hematuria. N Engl J Med. 2003;348(23):2330–2338.
- Kang M, Lee S, Jeong SJ, et al. Characteristics and significant predictors of detecting underlying diseases in adults with asymptomatic microscopic hematuria: a large case series of a Korean population. Int Urogynecol J. 2015;22(4):389–393.
- Davis R, Jones JS, Barocas DA, et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol. 2012;188(6 Suppl):2473–2481.
- Grossfeld GD, Litwin MS, Wolf JS, et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy–part I: definition, detection, prevalence, and etiology. Urology. 2001;57(4):599–603.
- Wollin T, Laroche B, Psooy K. Canadian guidelines for the management of asymptomatic microscopic hematuria in adults. Can Urol Assoc J. 2009;3(1):77–80.
- Oncology BSo, Jefferies ER, Brewster SF. Urological recommendations from the National Institute for Health and Care Excellence (NICE) Guideline, June 2015: suspected cancer: recognition and referral. BJU Int. 2016;117(6):857–860.
- Thaller TR, Wang LP. Evaluation of asymptomatic microscopic hematuria in adults. Am Fam Physician. 1999;60(4):1143–1152, 1154.
- Hockberger RS, Schwartz B, Connor J. Hematuria induced by urethral catheterization. Ann Emerg Med. 1987;16(5):550–552.
- Sharp VJ, Barnes KT, Erickson BA. Assessment of asymptomatic microscopic hematuria in adults. Am Fam Physician. 2013;88(11):747–754.
- Rao PK, Jones JS. How to evaluate ‘dipstick hematuria’: what to do before you refer. Cleve Clin J Med. 2008;75(3):227–233.
- Fraser CG. Urine analysis: current performance and strategies for improvement. Br Med J. 1985;291(6491):321–323.
- Dowell AC, Britton JP. Microhaematuria in general practice: is urine microscopy misleading? Br J Gen Pract. 1990;40(331):67–68.
- Kouri T, Malminiemi O, Penders J, et al. Limits of preservation of samples for urine strip tests and particle counting. Clin Chem Lab Med. 2008;46(5):703–713.
- Kelly JD, Fawcett DP, Goldberg LC. Assessment and management of non-visible haematuria in primary care. Bmj. 2009;338:a3021.
- Lynch TH, Waymont B, Dunn JA, et al. Repeat testing for haematuria and underlying urological pathology. Br J Urol. 1994;74(6):730–732.
- Gleeson MJ, Connolly J, Grainger R, et al. Comparison of reagent strip (dipstick) and microscopic haematuria in urological out-patients. Br J Urol. 1993;72(5 Pt 1):594–596.
- Britton JP, Dowell AC, Whelan P. Dipstick haematuria and bladder cancer in men over 60: results of a community study. Bmj. 1989;299(6706):1010–1012.
- Rao PK, Gao T, Pohl M, et al. Dipstick pseudohematuria: unnecessary consultation and evaluation. J Urol. 2010;183(2):560–564.
- Niemi MA, Cohen RA. Evaluation of microscopic hematuria: a critical review and proposed algorithm. Adv Chronic Kidney Dis. 2015;22(4):289–296.
- Huussen J, Koene RA, Meuleman EJ, et al. Diagnostic approach in patients with asymptomatic haematuria: efficient or not? Int J Clin Pract. 2006;60(5):557–561.
- Mohr DN, Offord KP, Owen RA, et al. Asymptomatic microhematuria and urologic disease. A population-based study. JAMA. 1986;256(2):224–229.
- Ritchie CD, Bevan EA, Collier SJ. Importance of occult haematuria found at screening. Br Med J. 1986;292(6521):681–683.
- Woolhandler S, Pels RJ, Bor DH, et al. Dipstick urinalysis screening of asymptomatic adults for urinary tract disorders. I. Hematuria and proteinuria. JAMA. 1989;262(9):1214–1219.
- Messing EM, Young TB, Hunt VB, et al. Home screening for hematuria: results of a multiclinic study. J Urol. 1992;148(2 Pt 1):289–292.
- Harmanli O, Yuksel B. Asymptomatic microscopic hematuria in women requires separate guidelines. Int Urogynecol J. 2013;24(2):203–206.
- Sutton JM. Evaluation of hematuria in adults. JAMA. 1990;263(18):2475–2480.
- Pillalamarri N, Shalom D, Sanidad S, et al. The prevalence of microscopic hematuria in a cohort of women with pelvic organ prolapse. Int Urogynecol J. 2015;26(1):85–90.
- Sandhu KS, LaCombe JA, Fleischmann N, et al. Gross and microscopic hematuria: guidelines for obstetricians and gynecologists. Obstet Gynecol Surv. 2009;64(1):39–49.
- Abarbanel J, Benet AE, Lask D, et al. Sports hematuria. J Urol. 1990;143(5):887–890.
- Shephard RJ. Exercise proteinuria and hematuria: current knowledge and future directions. J Sports Med Phys Fitness. 2016;56(9):1060–1076.
- Bellinghieri G, Savica V, Santoro D. Renal alterations during exercise. J Ren Nutr. 2008;18(1):158–164.
- Ajani UA, Ford ES, Greenland KJ, et al. Aspirin use among U.S. adults: behavioral risk factor surveillance system. Am J Prev Med. 2006;30(1):74–77.
- Hurlen M, Eikvar L, Seljeflot I, et al. Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis. Thromb Res. 2006;118(4):433–438.
- Jeong CW, Lee S, Byun SS, et al. No increase in risk of microscopic hematuria with aspirin use by asymptomatic healthy people. JAMA Intern Med. 2013;173(12):1145–1146.
- van Savage JG, Fried FA. Anticoagulant associated hematuria: a prospective study. J Urol. 1995;153(5):1594–1596.
- Floege J, Eitner F. Current therapy for IgA nephropathy. Jasn. 2011;22(10):1785–1794.
- Kohler H, Wandel E, Brunck B. Acanthocyturia–a characteristic marker for glomerular bleeding. Kidney Int. 1991;40(1):115–120.
- Buckalew VM Jr., Berg RL, Wang SR, et al. Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of diet in renal disease study group. Am J Kidney Dis. 1996;28(6):811–821.
- Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289(18):2363–2369.
- Jung H, Gleason JM, Loo RK, et al. Association of hematuria on microscopic urinalysis and risk of urinary tract cancer. J Urol. 2011;185(5):1698–1703.
- Loo RK, Lieberman SF, Slezak JM, et al. Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clinic Proc. 2013;88(2):129–138.
- Khadra MH, Pickard RS, Charlton M, et al. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol. 2000;163(2):524–527.
- Sugimura K, Ikemoto SI, Kawashima H, et al. Microscopic hematuria as a screening marker for urinary tract malignancies. Int Urogynecol J. 2001;8(1):1–5.
- El-Galley R, Abo-Kamil R, Burns JR, et al. Practical use of investigations in patients with hematuria. J Endourology /Endourological Soc. 2008;22(1):51–56.
- Messing EM, Young TB, Hunt VB, et al. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. Urology. 1995;45(3):387-396; discussion 396-387.
- Mayfield MP, Whelan P. Bladder tumours detected on screening: results at 7 years. Br J Urol. 1998;82(6):825–828.
- Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2007;57(1):43–66.
- Samanic C, Kogevinas M, Dosemeci M, et al. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev. 2006;15(7):1348–1354.
- Zeegers MP, Tan FE, Dorant E, et al. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer. 2000;89(3):630–639.
- Mariani AJ, Mariani MC, Macchioni C, et al. The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol. 1989;141(2):350–355.
- Jones DJ, Langstaff RJ, Holt SD, et al. The value of cystourethroscopy in the investigation of microscopic haematuria in adult males under 40 years. A prospective study of 100 patients. Br J Urol. 1988;62(6):541–545.
- Murakami S, Igarashi T, Hara S, et al. Strategies for asymptomatic microscopic hematuria: a prospective study of 1,034 patients. J Urol. 1990;144(1):99–101.
- Aaronson DS, Walsh TJ, Smith JF, et al. Meta-analysis: does lidocaine gel before flexible cystoscopy provide pain relief? BJU Int. 2009;104(4):506-509;discussion 509-510.
- Burke DM, Shackley DC, O’Reilly PH. The community-based morbidity of flexible cystoscopy. BJU Int. 2002;89(4):347–349.
- Sudakoff GS, Dunn DP, Guralnick ML, et al. Multidetector computerized tomography urography as the primary imaging modality for detecting urinary tract neoplasms in patients with asymptomatic hematuria. J Urol. 2008;179(3):862-867;discussion 867.
- Townsend BA, Silverman SG, Mortele KJ, et al. Current use of computed tomographic urography: survey of the society of uroradiology. J Comput Assist Tomogr. 2009;33(1):96–100.
- Gray Sears CL, Ward JF, Sears ST, et al. Prospective comparison of computerized tomography and excretory urography in the initial evaluation of asymptomatic microhematuria. J Urol. 2002;168(6):2457–2460.
- Lang EK, Thomas R, Davis R, et al. Multiphasic helical computerized tomography for the assessment of microscopic hematuria: a prospective study. J Urol. 2004;171(1):237–243.
- Brooks JD. Anatomy of the lower urinary tract and male genitalia. In: Walsh PC, Campbell MF, editors. Campell’s Urology. Philadelphia: Saunders; 1998. p. 89–128.
- van der Molen AJ, Cowan NC, Mueller-Lisse UG, et al. CT urography: definition, indications and techniques. A guideline for clinical practice. Eur Radiol. 2008;18(1):4–17.
- O’Connor OJ, Fitzgerald E, Maher MM. Imaging of hematuria. AJR Am J Roentgenol. 2010;195(4):W263W267.
- Potenta SE, D’Agostino R, Sternberg KM, et al. Urography for Evaluation of the Ureter. Radiographics. 2015;35(3):709–726.
- Kawashima A, Vrtiska TJ, LeRoy AJ, et al. CT urography. Radiographics. 2004;24(Suppl 1):S35-54; discussion S55-38.
- Takeuchi M, Konrad AJ, Kawashima A, et al. CT urography for diagnosis of upper urinary tract urothelial carcinoma: are both nephrographic and excretory phases necessary? AJR Am J Roentgenol. 2015;205(3):W320–327.
- Joffe SA, Servaes S, Okon S, et al. Multi-detector row CT urography in the evaluation of hematuria. Radiographics. 2003;23(6):1441-1455;discussion 1455-1446.
- McNicholas MM, Raptopoulos VD, Schwartz RK, et al. Excretory phase CT urography for opacification of the urinary collecting system. AJR Am J Roentgenol. 1998;170(5):1261–1267.
- Caoili EM, Cohan RH, Korobkin M, et al. Effectiveness of abdominal compression during helical renal CT. Acad Radiol. 2001;8(11):1100–1106.
- Chow LC, Sommer FG. Multidetector CT urography with abdominal compression and three-dimensional reconstruction. AJR Am J Roentgenol. 2001;177(4):849–855.
- Wang ZJ, Coakley FV, Joe BN, et al. Multidetector row CT urography: does supine or prone positioning produce better pelvecalyceal and ureteral opacification? Clin Imaging. 2009;33(5):369–373.
- Sanyal R, Deshmukh A, Singh Sheorain V, et al. CT urography: a comparison of strategies for upper urinary tract opacification. Eur Radiol. 2007;17(5):1262–1266.
- Chow LC, Kwan SW, Olcott EW, et al. MDCT urography with synchronous nephrographic and excretory phase enhancement. AJR Am J Roentgenol. 2007;189(2):314–322.
- Cowan NC, Turney BW, Taylor NJ, et al. Multidetector computed tomography urography for diagnosing upper urinary tract urothelial tumour. BJU Int. 2007;99(6):1363–1370.
- Tsili AC, Efremidis SC, Kalef-Ezra J, et al. Multi-detector row CT urography on a 16-row CT scanner in the evaluation of urothelial tumors. Eur Radiol. 2007;17(4):1046–1054.
- Catalano C, Fraioli F, Laghi A, et al. High-resolution multidetector CT in the preoperative evaluation of patients with renal cell carcinoma. AJR Am J Roentgenol. 2003;180(5):1271–1277.
- Smith-Bindman R, Miglioretti DL, Johnson E, et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010. JAMA. 2012;307(22):2400–2409.
- Fazel R, Krumholz HM, Wang Y, et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med. 2009;361(9):849–857.
- Brenner DJ, Hall EJ. Computed tomography–an increasing source of radiation exposure. N Engl J Med. 2007;357(22):2277–2284.
- Sountoulides P, Metaxa L, Cindolo L. Is computed tomography mandatory for the detection of residual stone fragments after percutaneous nephrolithotomy? J Endourology /Endourological Soc. 2013;27(11):1341–1348.
- Moloney F, Murphy KP, Twomey M, et al. Haematuria: an imaging guide. Adv Urol. 2014;2014:1–9.
- Lisanti CJ, Toffoli TJ, Stringer MT, et al. CT evaluation of the upper urinary tract in adults younger than 50 years with asymptomatic microscopic hematuria: is IV contrast enhancement needed? AJR Am J Roentgenol. 2014;203(3):615–619.
- Kiragu D, Cifu AS. Evaluation of patients with asymptomatic microhematuria. JAMA. 2015;314(17):1865–1866.
- Kawashima A, Glockner JF, King BF Jr. CT urography and MR urography. Radiol Clin North Am. 2003;41(5):945–961.
- Chahal R, Taylor K, Eardley I, et al. Patients at high risk for upper tract urothelial cancer: evaluation of hydronephrosis using high resolution magnetic resonance urography. J Urol. 2005;174(2):478-482;quiz 801.
- Leyendecker JR, Barnes CE, Zagoria RJ. MR urography: techniques and clinical applications. Radiographics. 2008;28(1):23-46;discussion 46-27.
- Sudah M, Masarwah A, Kainulainen S, et al. Comprehensive MR urography protocol: equally good diagnostic performance and enhanced visibility of the upper urinary tract compared to triple-Phase CT urography. Plos One. 2016;11(7):e0158673.
- Takahashi N, Glockner JF, Hartman RP, et al. Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy. J Urol. 2010;183(4):1330–1365.
- Takahashi N, Kawashima A, Glockner JF, et al. Small (<2-cm) upper-tract urothelial carcinoma: evaluation with gadolinium-enhanced three-dimensional spoiled gradient-recalled echo MR urography. Radiology. 2008;247(2):451–457.
- Childs DD, Leyendecker JR, Gianini J, et al. Contrast-enhanced magnetic resonance urography at 3T: clinical feasibility. J Comput Assist Tomogr. 2013;37(1):29–36.
- Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology. 2007;243(1):148–157.
- Jamis-Dow CA, Choyke PL, Jennings SB, et al. Small (< or = 3-cm) renal masses: detection with CT versus US and pathologic correlation. Radiology. 1996;198(3):785–788.
- Metaxa IT L, Sountoulides P, Kiryttopoulos P, et al. Cysts and cyst like renal tumors. The importance of the Bosniak classification system. Ecr. 2012;2012:13.
- Choyke PL. Radiologic evaluation of hematuria: guidelines from the American College of Radiology’s appropriateness criteria. Am Fam Physician. 2008;78(3):347–352.
- Browne RF, Meehan CP, Colville J, et al. Transitional cell carcinoma of the upper urinary tract: spectrum of imaging findings. Radiographics. 2005;25(6):1609–1627.
- Alvarellos CP, Carames LC, Castro SP, et al. Usefulness of the restriction-modification test plus staphylococcal cassette chromosome mec types and Panton-Valentine leukocidin encoding phages to identify Staphylococcus aureus methicillin-resistant clones. Scand J Infect Dis. 2011;43(11–12):943–946.
- Grossfeld GD, Litwin MS, Wolf JS Jr., et al. Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy–part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology. 2001;57(4):604–610.
- Grossman HB, Soloway M, Messing E, et al. Surveillance for recurrent bladder cancer using a point-of-care proteomic assay. JAMA. 2006;295(3):299–305.
- Brown FM. Urine cytology. It is still the gold standard for screening? Urol Clin North Am. 2000;27(1):25–37.
- Kumar A, Kumar R, Gupta NP. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer. Jpn J Clin Oncol. 2006;36(3):172–175.
- Nese N, Gupta R, Bui MH, et al. Carcinoma in situ of the urinary bladder: review of clinicopathologic characteristics with an emphasis on aspects related to molecular diagnostic techniques and prognosis. Jnccn. 2009;7(1):48–57.
- Raitanen MP, Aine R, Rintala E, et al. Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis. Eur Urol. 2002;41(3):284–289.
- Nakamura K, Kasraeian A, Iczkowski KA, et al. Utility of serial urinary cytology in the initial evaluation of the patient with microscopic hematuria. BMC Urol. 2009;9:12.
- Feifer AH, Steinberg J, Tanguay S, et al. Utility of urine cytology in the workup of asymptomatic microscopic hematuria in low-risk patients. Urology. 2010;75(6):1278–1282.
- Steiner H, Bergmeister M, Verdorfer I, et al. Early results of bladder-cancer screening in a high-risk population of heavy smokers. BJU Int. 2008;102(3):291–296.
- Miah S, Dudziec E, Drayton RM, et al. An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer. Br J Cancer. 2012;107(1):123–128.
- Karnes RJ, Fernandez CA, Shuber AP. A noninvasive multianalyte urine-based diagnostic assay for urothelial cancer of the bladder in the evaluation of hematuria. Mayo Clinic Proc. 2012;87(9):835–842.
- van Rhijn BW, van der Poel HG, van der Kwast TH. Urine markers for bladder cancer surveillance: a systematic review. Eur Urol. 2005;47(6):736–748.
- Boman H, Hedelin H, Holmang S. Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence. J Urol. 2002;167(1):80–83.
- Edwards TJ, Dickinson AJ, Gosling J, et al. Patient-specific risk of undetected malignant disease after investigation for haematuria, based on a 4-year follow-up. BJU Int. 2011;107(2):247–252.
- Madeb R, Golijanin D, Knopf J, et al. Long-term outcome of patients with a negative work-up for asymptomatic microhematuria. Urology. 2010;75(1):20–25.
- Carson CC 3rd, Segura JW, Greene LF. Clinical importance of microhematuria. JAMA. 1979;241(2):149–150.
- Tryggvason K, Patrakka J. Thin basement membrane nephropathy. Jasn. 2006;17(3):813–822.
- Pichler R, Heidegger I, Leonhartsberger N, et al. The need for repeated urological evaluation in low-risk patients with microscopic hematuria after negative diagnostic work-up. Anticancer Res. 2013;33(12):5525–5530.
- Koo KC, Lee KS, Choi AR, et al. Diagnostic impact of dysmorphic red blood cells on evaluating microscopic hematuria: the urologist’s perspective. Int Urol Nephrol. 2016;48(7):1021–1027.
- Buteau A, Seideman CA, Svatek RS, et al. What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up. Urol Oncol. 2014;32(2):128–134.
- Nieder AM, Lotan Y, Nuss GR, et al. Are patients with hematuria appropriately referred to Urology? A multi-institutional questionnaire based survey. Urol Oncol. 2010;28(5):500–503.
- Elias K, Svatek RS, Gupta S, et al. High-risk patients with hematuria are not evaluated according to guideline recommendations. Cancer. 2010;116(12):2954–2959.
- Friedlander DF, Resnick MJ, You C, et al. Variation in the intensity of hematuria evaluation: a target for primary care quality improvement. Am J Med. 2014;127(7):633–640e611.
- Shinagare AB, Silverman SG, Gershanik EF, et al. Evaluating hematuria: impact of guideline adherence on urologic cancer diagnosis. Am J Med. 2014;127(7):625–632.
- Ziemba J, Guzzo TJ, Ramchandani P. Evaluation of the patient with asymptomatic microscopic hematuria. Acad Radiol. 2015;22(8):1034–1037.